Marker Therapeutics, Inc. - Common Stock - Bilanço (NASDAQ:MRKR) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 45.61 M68.14 M34.42 M17.13 M22.02 M19.07 M Toplam yükümlülükler 18.27 M24.15 M14.82 M3.07 M3.46 M2.27 M Toplam özsermaye 27.34 M43.99 M19.6 M14.05 M18.56 M16.8 M Toplam yükümlülükler ve hissedarların özsermayesi 45.61 M68.14 M34.42 M17.13 M22.02 M19.07 M Toplam borç —————— Net borç ——————

Haberler

MARKER THERAPEUTICS (MRKR) Upgraded to Buy: What Does It Mean for the Stock?

H.C. Wainwright, Marker Therapeutics hissesi için alım tavsiyesini korudu

ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates

BioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue Estimates

H.C. Wainwright, Marker Therapeutics hissesi için al önerisini yineledi

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

Marker Therapeutics 2026 yılı hissedar toplantısı tarihini ve teklif son tarihini belirledi

Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?